Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 9:47:174.
doi: 10.11604/pamj.2024.47.174.41677. eCollection 2024.

Frequency and determinants of phytotherapy use in patients with type 2 diabetes in the Dschang Health District, Cameroon: a cross-sectional study

Michelle Carolle Dongmo Demanou  1 , Sylvain Raoul Simeni Njonnou  2   3 , André Arsène Bita Fouda  1 , Eric Balti  2   4   5 , Fernando Kemta Lekpa  2   6 , Christian Ngongang Ouankou  2   7 , Martine Claude Etoa Etoga  5   8 , Cédric Fritz Gerald Eyenga Bangbang  3 , Marie-Josiane Ntsama Essomba  5   8 , Anne Ongmeb Boli  4   9 , Fabrice Lekeufack  10 , Dieudonné Désiré Michel Adiogo  11
Affiliations

Frequency and determinants of phytotherapy use in patients with type 2 diabetes in the Dschang Health District, Cameroon: a cross-sectional study

Michelle Carolle Dongmo Demanou et al. Pan Afr Med J. .

Abstract

Introduction: phytotherapy is widely used in Africa for the management of many diseases. Data on the use of phytotherapy in people with type 2 diabetes are scarce. We aimed to determine the frequency and factors associated with the consumption/use of phytotherapy products among patients with type 2 diabetes in the Dschang Health District.

Methods: we conducted a cross-sectional study from January to May 2022, including community-dwelling or hospitalized patients with type 2 diabetes who had lived in the Dschang Health District for at least one year. Informed consent was obtained from all patients. Data were collected using a pre-designed questionnaire. Variables collected included socio-demographic characteristics, diabetes knowledge and practices, and perceptions of care.

Results: we included 403 (249 women) patients with type 2 diabetes with a mean (SD) age of 63 (± 14.86) years). Among them, 240 (59.55%) used phytotherapy, either in combination with conventional treatment (168 (41.69%) participants) or not (72 (17.86%) participants), to treat diabetes. The most common reasons for using phytotherapy were easy accessibility and belief in its efficacy. Most patients used both treatments because they thought the combination was more effective. In univariable analysis, we observed a statistically significant association between level of education (p=0.003), socioeconomic level (p<0.001), place of residence (p=0.003), duration of diabetes (p=0.007), and use of phytotherapy. In multivariable analysis, only age between 51 and 60 years (OR: 0.50, 95% CI 0.298 - 0.8521; p=0.01) was associated with the use of phytotherapy.

Conclusion: people living with T2D in the Dschang Health District frequently use phytotherapy as an antidiabetic remedy, especially those aged between 51 and 60 years, those with low education level, low socioeconomic level and medium duration of diabetes. There is a need to evaluate its effectiveness in treating diabetes and its adverse effects.

Keywords: Cameroon; Dschang; Phytotherapy consumption; risk factors; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
study population flowchart of participants recruited in the Dschang Health District
Figure 2
Figure 2
distribution of participants with type 2 diabetes recruited in the Dschang Health District by treatment preference
See this image and copyright information in PMC

References

    1. Organisation mondiale de la Santé . Genève: Organisation mondiale de la Santé; 2016. Rapport mondial sur le diabète.
    1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119. - PMC - PubMed
    1. Grossman LD, Roscoe R, Shack AR. Complementary and Alternative Medicine for Diabetes. Can J Diabetes. 2018;42(Suppl 1):S154–S161. - PubMed
    1. Organisation mondiale de la Santé . Genève: Organisation mondiale de la Santé; 2013. Stratégie de l´OMS pour la médecine traditionnelle pour 2014-2023.
    1. Barry JA. Living with type 2 diabetes mellitus in a modern Mexican city and opting for phytotherapy. Explore (NY) 2012 Jan-Feb;8(1):48–9. - PubMed

Substances